AzTrials
AzTrials

Sexually Transmitted DiseasesPhase 2/3NCT00164619

Testing the Effectiveness of VOICES as Implemented by STD & HIV Prevention Agencies in the US and PR

A Phase 2/3 study testing VOICES/VOCES and Standard STD clinic services in people with Sexually Transmitted Diseases, run by Centers for Disease Control and Prevention at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sexually Transmitted Diseases
What is being tested?
VOICES/VOCES and Standard STD clinic services
Could I receive a placebo?
No, everyone receives an active treatment
How many people
3,660 participants
Where
2 sitesin 2 countries
Study dates
Jul 2001to Mar 2008
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • STD infection at time of recruitment
  • Accept treatment for STD infection at time of recruitment

Who cannot join

  • Age under 18 years

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

United States1 site
  • Central Harlem STD Clinic

    New York, New York, 10037

Other trials in United States

Puerto Rico1 site
  • Centro Latino Americano de Enfermedades de Transmission Sexual

    San Juan, 00922

Other trials in Puerto Rico

About this study

Official title: Testing the Effectiveness of the VOICES/VOCES Intervention Package as Implemented by STD and HIV Prevention Agencies That Target Hispanics and African Americans in the U.S. and Puerto Rico

The purpose of the project is to determine whether the VOICES/VOCES intervention, that was shown to be effective in a research study, is still effective when delivered by STD/HIV prevention agencies.

VOICES/VOCES is a brief, single-session intervention for African-American and Latino adult men and women at high risk for STD/HIV. It encourages condom use and improves condom negotiation skills. A health educator delivers the intervention to groups of 4 to 8 clinic patients in a private room. Groups are made up of people of the same sex and same race or ethnicity. Information on STD/HIV risk behaviors and condom use is delivered by culturally-specific videos, group discussion, and a poster presenting features of various condom brands. Participants role-play condom negotiation modeled in the videos. At the end of the session they are given sample condoms of their choice.

In this project, health educators from the health departments of New York City and San Juan, Puerto Rico conducted the VOICES/VOCES intervention with a sample of patients from one STD clinic in each of their cities. Researchers helped the health departments test whether the intervention is effective when local health educators deliver it.

Read the detailed description

This project was an RCT with 1699 patients assigned to receive the VOICES/VOCES intervention and 1707 to receive standard of care at each of the two STD clinics (total N=3406). Participant outcomes and their measures are:

  1. Change in knowledge and attitudes about condoms as determined by participant profile and survey data
  2. Condom acquisition as determined by project coupon redemption data
  3. STD incidence as determined by medical chart review and/or surveillance data

In addition, cost accounting data on the amounts and types of resources required to implement the intervention were used to evaluate the intervention's cost-effectiveness. Process evaluation data allow identification of factors that influenced intervention implementation and the effectiveness of the intervention.

Being tested
VOICES/VOCES, Standard STD clinic services
Keywords
controlled clinical trial, behavioral intervention, prevention intervention
Medical subject headings
Sexually Transmitted Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VOICES/VOCESBehavioural

    Also called No other names

    45-minute intervention for small groups of African American and Hispanic heterosexual men and women. Group members are same gender and race/ethnicity. View culturally-specific condom promotion video. Facilitated group discussion to build skills in condom use and condom negotiation. Education on condom varieties to overcome participants' personal barriers to condoms use. Distribution of 3 specialty condoms of participant's choice (i.e., different sizes, textures, thicknesses, lubrication, material). [see Brief Summary above]

  • Standard STD clinic servicesBiological

    Also called No other names

    Individual physical exam, STD/HIV tests, treatment as indicated

Study groups in NCT00164619
Study groupRoleWhat they receive
1ExperimentalStandard STD clinic services and the VOICES/VOCES intervention
Receives: Behavioral: VOICES/VOCES
2Active comparatorStandard STD clinic services
Receives: Biological: Standard STD clinic services

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Repeat STD infection

    Measured: Average of 15-months post-intervention

Secondary outcomes (2)
  1. Change in knowledge and attitudes

    Measured: Immediately post-intervention

  2. Condom coupon redemption

    Measured: 3-months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Sep 2005 (estimated)
  2. Study startJul 2001
  3. Primary completionNov 2006
  4. Study completionMar 2008

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
3,660 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00164619
Sponsor's protocol ID
CDC-NCHSTP-4048
Other IDs
Contract 200-2001-00132
Status last verified
Jun 2008
First submitted
12 Sep 2005
Last updated
5 Jun 2008
Results posted
No
Data monitoring committee
No

Publications

  • O'Donnell CR, O'Donnell L, San Doval A, Duran R, Labes K. Reductions in STD infections subsequent to an STD clinic visit. Using video-based patient education to supplement provider interactions. Sex Transm Dis. 1998 Mar;25(3):161-8. doi: 10.1097/00007435-199803000-00010.

    PubMed 9524995

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing VOICES/VOCES and Standard STD clinic services in people with Sexually Transmitted Diseases, run by Centers for Disease Control and Prevention at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Jun 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United States, Puerto Rico. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Repeat STD infection (time frame: Average of 15-months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00164619, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in